Scott Nogi
Geschäftsführer bei DIANTHUS THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Scott Nogi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 | |
| Public Company | Biotechnology | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Scott Nogi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Highbridge Capital Management LLC
 Highbridge Capital Management LLC Investment ManagersFinance Highbridge Capital Management LLC (HCM Highbridge is a registered investment advisor and global alternative investment firm headquartered in New York City. The firm was founded in 1992 and is a subsidiary of JPMorgan Asset Management Holdings Inc., which is a wholly-owned subsidiary of JPMorgan Chase & Co. (NYSE: JPM). Highbridge manages capital for sophisticated investors, who include financial institutions, public and corporate pension funds, sovereign wealth funds, endowments and family offices. | Investment Managers | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Investment Managers | Private Equity Investor Chief Investment Officer Private Equity Investor | |
| ACCELERON PHARMA INC. | Biotechnology | Compliance Officer Human Resources Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| TESARO INC | Pharmaceuticals: Major | Founder Investor Relations Contact | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| George Washington University | College/University | Undergraduate Degree Graduate Degree | |
| Temple University (Pennsylvania) | College/University | Director/Board Member Masters Business Admin | |
| Tufts University | College/University | Graduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chairman Founder Director/Board Member Chief Executive Officer Director/Board Member | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | General Counsel Founder Human Resources Officer General Counsel | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Founder | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Barnard College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
Viridian LLC
 Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer Founder | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Biotechnology | Chief Executive Officer Chairman | |
| University of Arizona | College/University | Doctorate Degree Masters Business Admin | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
UBS AG (Private Banking UK)
 UBS AG (Private Banking UK) Investment ManagersFinance UBS AG (Private Banking UK) is the Great Britain-based private banking division of UBS AG (London Branch), ultimately held by UBS Group AG (NYSE: UBS, SWX: UBSG) in Switzerland. Headquartered in London, the firm was founded 1998 and provides a range of private banking services to high-net worth clients. | Investment Managers | Analyst-Equity | |
| HEALTHTECH SOLUTIONS INC. | Packaged Software | Chairman | |
Dioko Ventures
 Dioko Ventures Investment ManagersFinance Dioko Ventures (Dioko Ventures) is a venture capital subsidiary of Clayton Associates Holdings LLC. The firm is headquartered in Winston-Salem, North California. | Investment Managers | Consultant / Advisor | |
| University of North Carolina at Chapel Hill | College/University | Corporate Officer/Principal | |
| ASP ISOTOPES INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 44 |
| Kanada | 3 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Finance | 7 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 171 |
| Corporate Officer/Principal | 103 |
| Independent Dir/Board Member | 62 |
| Chief Tech/Sci/R&D Officer | 43 |
| Chief Executive Officer | 42 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Lonnie Moulder | 31 |
| Alison Lawton | 25 |
| Anne McGeorge | 25 |
| Brian Pereira | 23 |
| Shawn Tomasello | 22 |
| George Migausky | 18 |
| Jeffrey Davis | 17 |
| Paul Mann | 17 |
| Stephen B. Howell | 16 |
| Joao Siffert | 14 |
| Faith Charles | 14 |
| Mark Alvino | 13 |
| Paula Soteropoulos | 13 |
| Lei Meng | 12 |
| Victor Paulus | 12 |
- Börse
- Insiders
- Scott Nogi
- Unternehmensverbindungen
